Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy
- PMID: 20177338
- DOI: 10.1097/TP.0b013e3181c90287
Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy
Abstract
Background: Outcomes after deceased heart beating donor kidney transplantation are good, but survival rates vary according to a number of donor-, recipient-, and transplant-related factors. This comprehensive analysis of transplant outcomes was undertaken to inform development of a new Kidney Allocation Scheme.
Methods: A complete case analysis of the outcome of kidney-only transplants in the United Kingdom, 1995 to 2001, was undertaken using Cox regression modeling. Seven thousand three hundred eighty-five (77%) of the 9585 transplants reported to the UK Transplant Registry were primary transplants in adults. Regrafts and pediatric patients (age <18 years) were analyzed separately. Transplant and patient survival over 5 years were investigated in addition to causes of prolonged cold ischemia time (CIT).
Results: A variety of factors significantly adversely influenced kidney transplant and patient outcome, including older donor age, older recipient age, waiting time to transplant over 2 years, diabetes, and earlier year of transplant. Human leukocyte antigen mismatch and CIT were significant in analyses of transplant but not in patient outcome, and an increased graft failure rate was also identified in adolescent patients. CIT was prolonged by long-distance kidney exchanges between centers (2 hr) and reallocation of kidneys for alternative patients (7 hr).
Conclusion: This study identified a number of factors that influence transplant outcome after deceased heart beating donor kidney transplant in the United Kingdom. The findings suggest that the influences of human leukocyte antigen mismatch and CIT are most relevant in considering a revised kidney allocation scheme.
Similar articles
-
A multi-factor analysis of kidney regraft outcomes.Clin Transpl. 2002:335-49. Clin Transpl. 2002. PMID: 12971460
-
Kidney transplantation in the United States.Clin Transpl. 2008:1-18. Clin Transpl. 2008. PMID: 19711510
-
A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys.Transplantation. 2010 Feb 27;89(4):387-94. doi: 10.1097/TP.0b013e3181c9029d. Transplantation. 2010. PMID: 20177339
-
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004.Clin Transplant. 2005 Aug;19(4):433-55. doi: 10.1111/j.1399-0012.2005.00378.x. Clin Transplant. 2005. PMID: 16008587 Review.
-
HLA compatibility and organ transplant survival. Collaborative Transplant Study.Rev Immunogenet. 1999;1(3):334-42. Rev Immunogenet. 1999. PMID: 11256424 Review.
Cited by
-
What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients.BMC Nephrol. 2018 May 18;19(1):116. doi: 10.1186/s12882-018-0908-3. BMC Nephrol. 2018. PMID: 29776389 Free PMC article.
-
Compatibility and kidney transplantation: the way to go.Front Immunol. 2012 May 14;3:111. doi: 10.3389/fimmu.2012.00111. eCollection 2012. Front Immunol. 2012. PMID: 22593759 Free PMC article.
-
Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.Clin Exp Nephrol. 2019 Jun;23(6):807-813. doi: 10.1007/s10157-019-01710-z. Epub 2019 Feb 27. Clin Exp Nephrol. 2019. PMID: 30809748
-
Allocating deceased donors using local vs. imported renal allografts: Logistics are more important than distance.Surg Pract Sci. 2023 May 3;13:100175. doi: 10.1016/j.sipas.2023.100175. eCollection 2023 Jun. Surg Pract Sci. 2023. PMID: 39845391 Free PMC article.
-
'Off-the-shelf' allogeneic CAR T cells: development and challenges.Nat Rev Drug Discov. 2020 Mar;19(3):185-199. doi: 10.1038/s41573-019-0051-2. Epub 2020 Jan 3. Nat Rev Drug Discov. 2020. PMID: 31900462 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical